Assessment of Phantom Dosimetry and Image Quality of I-CAT FLX Cone-beam Computed Tomography
Overview
Authors
Affiliations
Introduction: The increasing use of cone-beam computed tomography in orthodontics has been coupled with heightened concern about the long-term risks of x-ray exposure in orthodontic populations. An industry response to this has been to offer low-exposure alternative scanning options in newer cone-beam computed tomography models.
Methods: Effective doses resulting from various combinations of field of view size and field location comparing child and adult anthropomorphic phantoms with the recently introduced i-CAT FLX cone-beam computed tomography unit (Imaging Sciences, Hatfield, Pa) were measured with optical stimulated dosimetry using previously validated protocols. Scan protocols included high resolution (360° rotation, 600 image frames, 120 kV[p], 5 mA, 7.4 seconds), standard (360°, 300 frames, 120 kV[p], 5 mA, 3.7 seconds), QuickScan (180°, 160 frames, 120 kV[p], 5 mA, 2 seconds), and QuickScan+ (180°, 160 frames, 90 kV[p], 3 mA, 2 seconds). Contrast-to-noise ratio was calculated as a quantitative measure of image quality for the various exposure options using the QUART DVT phantom.
Results: Child phantom doses were on average 36% greater than adult phantom doses. QuickScan+ protocols resulted in significantly lower doses than standard protocols for the child (P = 0.0167) and adult (P = 0.0055) phantoms. The 13 × 16-cm cephalometric fields of view ranged from 11 to 85 μSv in the adult phantom and 18 to 120 μSv in the child phantom for the QuickScan+ and standard protocols, respectively. The contrast-to-noise ratio was reduced by approximately two thirds when comparing QuickScan+ with standard exposure parameters.
Conclusions: QuickScan+ effective doses are comparable with conventional panoramic examinations. Significant dose reductions are accompanied by significant reductions in image quality. However, this trade-off might be acceptable for certain diagnostic tasks such as interim assessment of treatment results.
Ozer N, Ulusoy A, Ilhan B, Lindfors N, Boyacioglu H, Grondahl H Imaging Sci Dent. 2025; 54(4):362-369.
PMID: 39744556 PMC: 11685310. DOI: 10.5624/isd.20240096.
Bayraktar Nahir C, Citir M, Colak S, Keldal G BMC Oral Health. 2024; 24(1):1068.
PMID: 39261834 PMC: 11391848. DOI: 10.1186/s12903-024-04813-6.
Santos A, de Freitas Silva B, Correia F, Mezaiko E, de Souza Roriz C, Silva M Imaging Sci Dent. 2024; 54(2):159-169.
PMID: 38948188 PMC: 11211023. DOI: 10.5624/isd.20230251.
Koivisto J, Wolff J, Pauwels R, Kaasalainen T, Suomalainen A, Stoor P Dentomaxillofac Radiol. 2024; 53(6):423-433.
PMID: 38913866 PMC: 11358642. DOI: 10.1093/dmfr/twae026.
Becker K, Ehrlich H, Hufner M, Rauch N, Busch C, Schwarz-Herzke B Oral Radiol. 2024; 40(3):424-435.
PMID: 38683260 PMC: 11180636. DOI: 10.1007/s11282-024-00748-4.